by Svendt | Jan 18, 2016 | Articles
BIA 10-2474 THERAPEUTIC TEST GOES FATAL IN FRANCE. WHAT DID HAPPEN ? WHAT ARE THE REAL RISKS IN PHASE I CLINICAL TRIALS ? WHAT IS A CLINICAL TRIAL? A clinical test normally takes place in 3 phases and the drug development may take in total between 10 and 15...
by Svendt | Nov 1, 2015 | Articles
What is new in ICH? How it will affect us and how? After 25 years of successful harmonisation ICH announces organisational changes Geneva, 26 October 2015 . ICH PRESS RELEASE The International Council for Harmonisation (ICH), formerly the International...
by Svendt | Oct 13, 2015 | Events
Intéressé de travailler en recherche clinique et affaires réglementaires de l’industrie pharmaceutique? Le Groupe Accès Pharma va participer à l’édition 2015 de la Foire nationale de l’emploi qui aura lieu cette semaine, soit les jeudi et vendredi, 15 et...
by Svendt | Aug 23, 2015 | Events
Pharmacovigilance Specialist – ref. 228PV-HP The Pharmacovigilance Specialist is needed in Montreal who will be responsible for: • Maintaining an efficient vigilance system in compliance with the Health Canada regulations and guidelines Participating in other...
by Svendt | Aug 20, 2015 | Articles
The outlines of the world pharmaceutical industry are consistently changing. If certain partners, as those of the pharmaceutical sales, are struggling, no such thing for the CROs, rapidly expanding. The figures are evident: the total number of research projects keeps...
